TickerFacts.

Anika Therapeutics, Inc. (ANIK): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$49.01M
Year ended 2025-12-31
$45.65M
Trailing 12 months to 2026-06-30
+6.5%
3-year compound annual growth
$64.85M2009-12-31: $13.67M2010-12-31: $23.83M2011-12-31: $26.78M2012-12-31: $28.99M2013-12-31: $22.77M2014-12-31: $20.93M2015-12-31: $21.05M2016-12-31: $24.03M2017-12-31: $27.36M2018-12-31: $31.28M2019-12-31: $28.75M2020-12-31: $61.43M2021-12-31: $64.85M2022-12-31: $40.61M2023-12-31: $38.26M2024-12-31: $43.91M2025-12-31: $49.01M$49.01M
2009-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$49.01M+11.6%2026-03-03, From 2025-01-01
2024-12-31$43.91M+14.8%2026-03-03, From 2024-01-01
2023-12-31$38.26M-5.8%2026-03-03, From 2023-01-01
2022-12-31$40.61Mn/c2025-03-17, From 2022-01-01
2021-12-31$64.85M+5.6%2024-03-15, From 2021-01-01
2020-12-31$61.43M+113.7%2023-03-16, From 2020-01-01
2019-12-31$28.75M-8.1%2022-03-11, From 2019-01-01
2018-12-31$31.28M+14.3%2021-04-26, From 2018-01-01
2017-12-31$27.36M+13.9%2020-03-06, From 2017-01-01
2016-12-31$24.03M+14.1%2019-02-27, From 2016-01-01
2015-12-31$21.05M+0.6%2018-02-27, From 2015-01-01
2014-12-31$20.93M-8.1%2017-02-24, From 2014-01-01
2013-12-31$22.77M-21.5%2016-03-10, From 2013-01-01
2012-12-31$28.99M+8.2%2015-03-13, From 2012-01-01
2011-12-31$26.78M+12.4%2014-03-13, From 2011-01-01
2010-12-31$23.83M+74.3%2013-03-14, From 2010-01-01
2009-12-31$13.67Mn/a2012-03-13, From 2009-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Anika Therapeutics, Inc. (ANIK)2025-12-31$49.01M+11.6%
Orasure Technologies Inc (OSUR)2025-12-31$66.82M-37.2%
Beta Bionics, Inc. (BBNX)2025-12-31$44.71M+52.9%
NeuroPace Inc (NPCE)2025-12-31$22.77M+9.3%
Kestra Medical Technologies, Ltd. (KMTS)2026-04-30$46.26M+29.9%
Xtant Medical Holdings, Inc. (XTNT)2025-12-31$49.65M+1.2%
Pulmonx Corp (LUNG)2025-12-31$23.36M+7.2%
InfuSystem Holdings, Inc (INFU)2025-12-31$63.14M-2.0%
Neuronetics, Inc. (STIM)2025-12-31$76.85M+270.7%

Compare ANIK, OSUR, BBNX, NPCE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗